Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?

Falk, 1990, Cellular peptide composition governed by major histocompatibility complex class I molecules, Nature, 348, 248, 10.1038/348248a0 Falk, 1991, Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules, Nature, 351, 290, 10.1038/351290a0 Falk, 1994, Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics, 39, 230, 10.1007/BF00188785 Chicz, 1994, Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8, Int lmmunol, 6, 1639, 10.1093/intimm/6.11.1639 Hunt, 1992, Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad, Science, 256, 1817, 10.1126/science.1319610 Todd, 1987, HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus, Nature, 329, 599, 10.1038/329599a0 Fremont, 1998, Crystal structure of I-Ak in complex with a dominant epitope of lysozyme, Immunity, 8, 305, 10.1016/S1074-7613(00)80536-1 Scott, 1998, Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues [published erratum appears in Immunity 1998 Apr;8(4):531], Immunity, 8, 319, 10.1016/S1074-7613(00)80537-3 Corper, 2000, A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes, Science, 288, 505, 10.1126/science.288.5465.505 Latek, 2000, Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice, Immunity, 12, 699, 10.1016/S1074-7613(00)80220-4 Lee, 2001, Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes, Nat Immunol, 2, 501, 10.1038/88694 Gregori, 2000, The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library, Int Immunol, 12, 493, 10.1093/intimm/12.4.493 Hausmann, 1999, pH-dependent peptide binding properties of the type I diabetes- associated I-Ag7 molecule: rapid release of CLIP at an endosomal pH, J Exp Med, 189, 1723, 10.1084/jem.189.11.1723 Stratmann, 2000, The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder, J Immunol, 165, 3214, 10.4049/jimmunol.165.6.3214 Bhatnagar, 2001, Nonobese diabetic mice display elevated levels of class ll-associated invariant chain peptide associated with I-Ag7 on the cell surface, J Immunol, 166, 4490, 10.4049/jimmunol.166.7.4490 Carrasco-Marin, 1996, The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders, J Immunol, 156, 450, 10.4049/jimmunol.156.2.450 Munz, 2002, Peptide analysis, stability studies, and structural modeling explain contradictory peptide motifs and unique properties of the NOD mouse MHC class II molecule H2-A(g7), Eur J Immunol, 32, 2105, 10.1002/1521-4141(200208)32:8<2105::AID-IMMU2105>3.0.CO;2-Q Peterson, 1998, The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM, J Immunol, 161, 2961, 10.4049/jimmunol.161.6.2961 Reizis, 1997, Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice, Eur J Immunol, 27, 2478, 10.1002/eji.1830271003 Reizis, 1997, Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7, Int Immunol, 9, 43, 10.1093/intimm/9.1.43 Ettinger, 2000, Beta 57-Asp plays an essential role in the unique SDS stability of HLA- DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus, J Immunol, 165, 3232, 10.4049/jimmunol.165.6.3232 Nelson, 1993, Identification of two distinct properties of class II major histocompatibility complex-associated peptides, Proc Natl Acad Sci U S A, 90, 1227, 10.1073/pnas.90.4.1227 Nelson, 1996, Amino acid residues on the I-Ak alpha-chain required for the binding and stability of two antigenic peptides, J Immunol, 156, 176, 10.4049/jimmunol.156.1.176 Suri, 2002, In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket, J Immunol, 168, 1235, 10.4049/jimmunol.168.3.1235 Suri, 2005, Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity, J Clin Invest, 115, 2268, 10.1172/JCI25350 Suri, 2003, Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition, Proc Natl Acad Sci U S A, 100, 5330, 10.1073/pnas.0330859100 Chang, 2007, Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation–maximization alignment algorithm, Proteomics, 7, 367, 10.1002/pmic.200600584 Rammensee, 1999, SYFPEITHI: database for MHC ligands and peptide motifs, Immunogenetics, 50, 213, 10.1007/s002510050595 Kanagawa, 1998, Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction, Proc Natl Acad Sci U S A, 95, 1721, 10.1073/pnas.95.4.1721 Ridgway, 1996, Breaking self-tolerance in nonobese diabetic mice, J Exp Med, 183, 1657, 10.1084/jem.183.4.1657 Ridgway, 1998, Analysis of the role of variation of major histocompatibility complex class II expression on nonobese diabetic (NOD) peripheral T cell response, J Exp Med, 188, 2267, 10.1084/jem.188.12.2267 Stratmann, 2003, Susceptible MHC alleles, not background genes, select an autoimmune Tcell reactivity, J Clin lnvest, 112, 902, 10.1172/JCI18337 Ferlin, 2004, Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice, Eur J Immunol, 34, 2656, 10.1002/eji.200425413 Kishimoto, 2001, A defect in central tolerance in NOD mice, Nat Immunol, 2, 1025, 10.1038/ni726 Zucchelli, 2005, Defective central tolerance induction in NOD mice: genomics and genetics, Immunity, 22, 385, 10.1016/j.immuni.2005.01.015 Lesage, 2002, Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes, J Exp Med, 196, 1175, 10.1084/jem.20020735 Kanagawa, 1998, Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant, J Immunol, 161, 4489, 10.4049/jimmunol.161.9.4489 Wegmann, 1994, Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice, Eur J Immunol, 24, 1853, 10.1002/eji.1830240820 Daniel, 1995, Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice, Eur J Immunol, 25, 1056, 10.1002/eji.1830250430 Yu, 2000, Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes, Eur J Immunol, 30, 2497, 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J Levisetti, 2007, The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form, J Immunol, 178, 6051, 10.4049/jimmunol.178.10.6051 Hoglund, 1999, Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes, J Exp Med, 189, 331, 10.1084/jem.189.2.331 Gagnerault, 2002, Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice, J Exp Med, 196, 369, 10.1084/jem.20011353 Krogsgaard, 2005, Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivity, Nature, 434, 238, 10.1038/nature03391 Yachi, 2005, Nonstimulatory peptides contribute to antigen-induced CD8-T cell receptor interaction at the immunological synapse, Nat Immunol, 6, 785, 10.1038/ni1220 Fairchild, 1993, An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction, Int Immunol, 5, 1151, 10.1093/intimm/5.9.1151 Liu, 1995, Low avidity recognition of self-antigen by T cells permits escape from central tolerance, Immunity, 3, 407, 10.1016/1074-7613(95)90170-1